These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 27802328

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical Characteristics and Long-Term Outcomes of Late-Onset Multiple Sclerosis: A Swedish Nationwide Study.
    Mouresan EF, Mentesidou E, Berglund A, McKay KA, Hillert J, Iacobaeus E.
    Neurology; 2024 Mar 26; 102(6):e208051. PubMed ID: 38394472
    [Abstract] [Full Text] [Related]

  • 4. Older Age at Multiple Sclerosis Onset Is an Independent Factor of Poor Prognosis: A Population-Based Cohort Study.
    Guillemin F, Baumann C, Epstein J, Kerschen P, Garot T, Mathey G, Debouverie M, LORSEP Group.
    Neuroepidemiology; 2017 Mar 26; 48(3-4):179-187. PubMed ID: 28793296
    [Abstract] [Full Text] [Related]

  • 5. Clinical characteristics of patients with late-onset multiple sclerosis.
    Kis B, Rumberg B, Berlit P.
    J Neurol; 2008 May 26; 255(5):697-702. PubMed ID: 18283394
    [Abstract] [Full Text] [Related]

  • 6. Clinical Characteristics and Disability Progression of Early- and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis.
    Mirmosayyeb O, Brand S, Barzegar M, Afshari-Safavi A, Nehzat N, Shaygannejad V, Sadeghi Bahmani D.
    J Clin Med; 2020 May 02; 9(5):. PubMed ID: 32370288
    [Abstract] [Full Text] [Related]

  • 7. Effect of gender on late-onset multiple sclerosis.
    Bove RM, Healy B, Augustine A, Musallam A, Gholipour T, Chitnis T.
    Mult Scler; 2012 Oct 02; 18(10):1472-9. PubMed ID: 22383227
    [Abstract] [Full Text] [Related]

  • 8. Late onset multiple sclerosis: concerns in aging patients.
    Lotti CBC, Oliveira ASB, Bichuetti DB, Castro I, Oliveira EML.
    Arq Neuropsiquiatr; 2017 Jul 02; 75(7):451-456. PubMed ID: 28746432
    [Abstract] [Full Text] [Related]

  • 9. Disability trajectories by progression independent of relapse activity status differ in pediatric, adult and late-onset multiple sclerosis.
    Simone M, Lucisano G, Guerra T, Paolicelli D, Rocca MA, Brescia Morra V, Patti F, Annovazzi P, Gasperini C, De Luca G, Ferraro D, Margari L, Granella F, Pozzilli C, Romano S, Perini P, Bergamaschi R, Coniglio MG, Lus G, Vianello M, Lugaresi A, Portaccio E, Filippi M, Amato MP, Iaffaldano P, Italian Multiple Sclerosis Register.
    J Neurol; 2024 Oct 02; 271(10):6782-6790. PubMed ID: 39179712
    [Abstract] [Full Text] [Related]

  • 10. Comparative analysis of cognitive and physical characteristics in late-onset, adult-onset and early-onset multiple sclerosis patients.
    Ozakbas S, Kaya E, Aslan T, Ozdogar AT, Baba C.
    Mult Scler Relat Disord; 2024 Oct 02; 90():105810. PubMed ID: 39180837
    [Abstract] [Full Text] [Related]

  • 11. Late-onset and young-onset relapsing-remitting multiple sclerosis: evidence from a retrospective long-term follow-up study.
    D'Amico E, Patti F, Zanghì A, Chisari CG, Lo Fermo S, Zappia M.
    Eur J Neurol; 2018 Dec 02; 25(12):1425-1431. PubMed ID: 29956427
    [Abstract] [Full Text] [Related]

  • 12. Late-onset MS is associated with an increased rate of reaching disability milestones.
    Andersen MA, Buron MD, Magyari M.
    J Neurol; 2021 Sep 02; 268(9):3352-3360. PubMed ID: 33677675
    [Abstract] [Full Text] [Related]

  • 13. Characterization of a late-onset multiple sclerosis Portuguese cohort.
    Moura J, Duarte S, Oliveira V, Pereira D, Costa D, Samões R, Sousa AP, Silva AM, Santos E.
    Mult Scler Relat Disord; 2023 Feb 02; 70():104506. PubMed ID: 36638770
    [Abstract] [Full Text] [Related]

  • 14. Alcohol, coffee, fish, smoking and disease progression in multiple sclerosis.
    D'hooghe MB, Haentjens P, Nagels G, De Keyser J.
    Eur J Neurol; 2012 Apr 02; 19(4):616-24. PubMed ID: 22117611
    [Abstract] [Full Text] [Related]

  • 15. Late-onset multiple sclerosis: disability trajectories in relapsing-remitting patients of the Italian MS Registry.
    Lorefice L, Ferraro OE, Fenu G, Amato MP, Bresciamorra V, Conte A, De Luca G, Ferraro D, Filippi M, Gazzola P, Iaffaldano P, Inglese M, Lus G, Marfia GA, Patti F, Pesci I, Salemi G, Trojano M, Zaffaroni M, Monti MC, Cocco E, Italian MS Register.
    J Neurol; 2024 Apr 02; 271(4):1630-1637. PubMed ID: 38172380
    [Abstract] [Full Text] [Related]

  • 16. Multiple sclerosis in older adults: the clinical profile and impact of interferon Beta treatment.
    Shirani A, Zhao Y, Petkau J, Gustafson P, Karim ME, Evans C, Kingwell E, van der Kop ML, Oger J, Tremlett H.
    Biomed Res Int; 2015 Apr 02; 2015():451912. PubMed ID: 25922836
    [Abstract] [Full Text] [Related]

  • 17. Early onset multiple sclerosis and the effect of disease onset age on neurological disability in multiple sclerosis.
    Usta NC, Boz C, Terzi M.
    Clin Neurol Neurosurg; 2023 Jan 02; 224():107528. PubMed ID: 36446265
    [Abstract] [Full Text] [Related]

  • 18. Clinical Features of Late-Onset Multiple Sclerosis: a Systematic Review and Meta-analysis.
    Naseri A, Nasiri E, Sahraian MA, Daneshvar S, Talebi M.
    Mult Scler Relat Disord; 2021 May 02; 50():102816. PubMed ID: 33571792
    [Abstract] [Full Text] [Related]

  • 19. Late-onset multiple sclerosis in Iran: A report on demographic and disease characteristics.
    Ghadiri F, Sahraian MA, Razazian N, Ashtari F, Poursadeghfard M, Nabavi SM, Navardi S, Baghbanian SM, Shaygannejad V, Harirchian MH, Beladimoghadam N, Majdinasab N, Hosseini S, Azimi A, Kamali H, Sharifipour E, Hosseini Nejad Mir N, Bayati A, Nahayati MA, Heidari H, Mozhdehipanah H, Ghalyanchi Langroodi H, Jalali N, Ayoubi S, Asadollahzadeh E, Ebadi Z, Eskandarieh S, Naser Moghadasi A.
    Mult Scler Relat Disord; 2023 Feb 02; 70():104493. PubMed ID: 36638768
    [Abstract] [Full Text] [Related]

  • 20. Natural history of multiple sclerosis in a population-based cohort.
    Debouverie M, Pittion-Vouyovitch S, Louis S, Guillemin F, LORSEP Group.
    Eur J Neurol; 2008 Sep 02; 15(9):916-21. PubMed ID: 18637953
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.